Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 459-520-5 | CAS number: 132182-92-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
The mutagenic activity of the test article was evaluated in the Salmonella typhimurium reverse mutation assay (strains: TA1535, TA1537, TA98 and TA100, histidine-requiring) and the Escherichia coli reverse mutation assay (strain: WP2uvrA, tryptophan-requiring) in the presence and absence of a metabolic activation system (S9-mix: rat liver S9-mix induced by a combination of phenobarbital and ß naphthoflavone). The study was conducted in compliance with OECD GLP regulations (1997). The test method was based on OECD 471 (1997). The test material was dissolved in ethanol (vehicle). A combined rangefinding test/first mutation assay was conducted in all strains with concentrations up to 5000 ug/plate in the presence and absence of S-9 mix. The test article precipitated on the plates at the 5000 ug/plate dose level. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed. In the second mutation assay the test article was tested up to concentrations of 5000 ug/plate in the presence and absence of S-9 mix. The test article precipitated at the highest dose level. The bacterial background lawn was not reduced at any of the concentrations tested and no decrease in the number of revertant colonies was observed. The test article did not induce a dose-related increase in the number of revertant colonies in any of the tester strains in the presence or absence of metabolic activation. Based on the results of the study, the test article is not mutagenic in the bacterial reverse mutation assay.
The
chromosome aberration potential of the test article was evaluated in
human blood peripheral lymphocytes in the presence and absence of
metabolic activation (S9-mix: Phenobarbital and B-napthoflavone induced
rat liver). The study was performed in compliance with OECD GLP (1997).
The test method was based on OECD 473 (1997) and EEC Directive
2000/32/EC, Part B: Methods for the Determination of Toxicity; B.10
(2000). The
MTDID test material was prepared in ethanol prior to administration. The
assay was performed in two independent experiments. In the first assay,
cells were tested up to a test article dose of 333 ug/mL for a 3-hour
exposure with a 24-hour fixation time in the presence and absence of S9
mix. In the second assay, the cells were tested to up to 333 ug/mL test
article dose for a 24-hour continuous exposure with a 24-hour fixation
time and up to a 333 ug/mL dose for a 48-hour exposure with a 48-hour
fixation time in the absence of S9-mix. The test article was also tested
at a 333 ug/mL dose for a 3-hour exposure with a 48-hour fixation time
in the presence of S9-mix. All dose levels were performed in duplicate
and positive and negative controls were tested in parallel. The test
article did not induce a statistically significant or biologically
relevant increase in the number of cells with chromosome aberrations in
two independent experiments. Based
on the results of the study, the test article is not clastogenic in
human lymphocytes in the presence or absence of metabolic activation.
The test substance MTDID 665 was evaluated for its clastogenic
potential in the micronucleus assay in male Sprague Dawley rats. The
study was conducted according to OECD 474 in compliance with OECD GLP.
Test substance formulations were administered once per day for two
consecutive days at a dose volume based on body weights via oral gavage.
No vehicle control was used in the study; animals in Group 1 in the
definitive assay were untreated. In the dose range-finding assay (DRF),
the dose levels tested were 1500 and 2000 mg/kg (dose volume 0.91 and
1.21 mL/kg, respectively) in 3 animals/sex. Based upon the results, the
high dose for the definitive assay was 2000 mg/kg, which is the
guideline recommended limit dose. The definitive dose levels were 500,
1000, and 2000 mg/kg/ (dose volume 0.30, 0.60 and 1.21 mg/kg
respectively). There were significant increases in the incidence of
micronuclei in the test substance dosed animals as compared to the
untreated control in the mid and high dose levels (1000 and 2000
mg/kg/day), however, as these values are within the 95% control limit of
the historical control data, they are considered to not be of biological
significance. Positive and untreated control values were within the
expected range and there was a statistically significant increase in
micronuclei in the positive control group as compared to the vehicle
control. All criteria for a valid assay were met. Under the conditions
of this study, the administration of MTDID 665 at dose levels up to and
including a dose level of 2000 mg/kg was concluded to be negative in the
micronucleus assay.
The mutagenic potential of the test article (structural analog HFE-7500 (source substance)) was evaluated in the L5178Y/TK+/- Mouse Lymphoma Mutagenesis assay in either the presence or absence of metabolic activation (S9-mix: Aroclor 1254). This study was performed in compliance with OECD GLP. The study design was based on OECD 476, and EC Directive 2000/32/EC B.17. The test article was prepared in acetone (vehicle). In the mutagenesis assay, the test article administered to the cells at concentrations of 0.4, 4.1, 41.4, 414, or 4140 ug/mL in each assay. One assay was performed in the presence or absence of S9-mix for a 4 hour exposure with a confirmatory assay in the presence of S9-mix and a 4 hour exposure. The fourth assay was performed in the absence of S9-mix for a 24 hour exposure. Appropriate positive and negative controls were run concurrently. No test article-treated cultures exhibited mutant frequencies that were at least 126 mutants per million clonable cells over the vehicle control in any culture in either the presence or absence of metabolic activation. Also, there was no concentration-related increase in mutant frequency. No evidence of toxicity was observed in any of the cultures. The results from the positive controls and negative control indicated that the test was valid both with and without metabolic activation. Based on the results of this study, the test article was not mutagenic in either the presence or absence of S9 activation in the L5178Y/TK+/- Mouse Lymphoma Mutagenesis Assay
Short description of
key information:
In vitro and in vivo genetic toxicity studies have been conducted on
HFE-7300 and a structural analog, HFE-7500. The results of the studies
are:
Bacterial Reverse Mutation Assay: Negative when tested according to OECD
471.
Chromosome Aberration: Negative when tested according to OECD 473.
Rat Micronucleus Assay: Negative when tested according to OECD 474.
Mouse Lymphoma Assay:
Negative when tested according to OECD 476 (Conducted on Structural
Analog HFE-7500).
Endpoint Conclusion:
Criteria for classifying the test article as mutagenic are not met.
Justification for classification or non-classification
Criteria for classifying the test article as mutagenic are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)